Renal cell carcinoma with multiple bone metastases effectively treated by a combination of tyrosine kinase inhibitor, robot‐assisted partial nephrectomy, and metastasectomy
Key Clinical Message Maintaining a disease‐free status for a long time in cases of renal cell carcinoma with multiple bone metastases and repeated recurrences is challenging. What matters most in the multidisciplinary approach is the treatment strategy. Although this is a case where multidisciplinar...
Main Authors: | Atsuro Sawada, Masashi Takeda, Takayuki Goto, Shusuke Akamatsu, Takashi Kobayashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.8482 |
Similar Items
-
Nomogram Predicting Survival to Assist Decision-Making of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma
by: Kan Wu, et al.
Published: (2020-12-01) -
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
by: Margaret F. Meagher, et al.
Published: (2024-05-01) -
Robot-assisted partial nephrectomy for renal cell carcinoma in the isthmus of horseshoe kidney
by: Atsuro Sawada, et al.
Published: (2022-07-01) -
Metastasectomy for Hepatic Metastases from Adenoid Cystic Carcinoma of the Trachea
Published: (2009-06-01) -
Role of metastasectomy in the management of renal cell carcinoma
by: Mark Mikhail, et al.
Published: (2022-07-01)